ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.1232dup (p.Tyr411Ter)

dbSNP: rs2143465421
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV001580221 SCV001809855 pathogenic Glanzmann thrombasthenia 2021-04-20 reviewed by expert panel curation The ITGA2B nonsense variant NM_000419.5:c.1232dup (p.Tyr411Ter) is expected to introduce a premature termination codon and the resulting mRNA product is predicted to undergo nonsense mediated decay, leading to loss of normal protein function. This variant has been observed in heterozygosity in one individual with a phenotype specific for Glanzmann's thrombasthenia (GT) in trans with ITGA2B variant c.985G>T (p.Val329Phe) (Patient M, PMID: 12424194). Furthermore, this variant is absent from population databases. In summary, this variant meets criteria to be classified as pathogenic for GT. GT-specific criteria applied: PVS1, PM2_supporting, PP4_moderate.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.